Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Camp4 Therapeutics (CAMP) Accounts Payables (2023 - 2025)

Historic Accounts Payables for Camp4 Therapeutics (CAMP) over the last 3 years, with Q3 2025 value amounting to $585000.0.

  • Camp4 Therapeutics' Accounts Payables fell 8489.54% to $585000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $585000.0, marking a year-over-year decrease of 8489.54%. This contributed to the annual value of $1.2 million for FY2024, which is 1612.28% up from last year.
  • According to the latest figures from Q3 2025, Camp4 Therapeutics' Accounts Payables is $585000.0, which was down 8489.54% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Camp4 Therapeutics' Accounts Payables registered a high of $3.9 million during Q3 2024, and its lowest value of $585000.0 during Q3 2025.
  • Over the past 3 years, Camp4 Therapeutics' median Accounts Payables value was $1.2 million (recorded in 2024), while the average stood at $1.6 million.
  • Its Accounts Payables has fluctuated over the past 5 years, first skyrocketed by 1612.28% in 2024, then tumbled by 8489.54% in 2025.
  • Over the past 3 years, Camp4 Therapeutics' Accounts Payables (Quarter) stood at $1.0 million in 2023, then grew by 16.12% to $1.2 million in 2024, then crashed by 51.65% to $585000.0 in 2025.
  • Its Accounts Payables was $585000.0 in Q3 2025, compared to $1.2 million in Q2 2025 and $1.4 million in Q1 2025.